North America Asthma Drugs Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Medication (Quick Relief Medications and Long-Term Control Medications), Route of Administration (Inhaled, Prefilled Syringe/Vials, and Others), and Distribution Channel (Online Pharmacies, Hospital Pharmacies, and Retail Pharmacies)
The North America asthma drugs market is expected to reach US$ 13,978.13 million by 2028 from US$ 10,146.51 million in 2021; it is estimated to grow at a CAGR of 4.7% from 2021 to 2028.
The growth of the market is attributed to the rising prevalence of asthma and the growing exposure to coarse particulate matters. However, the unmet medical needs hamper the market growth.
According to a 2018 study titled “Low-level ozone has both respiratory and systemic effects in African American adolescents with asthma despite asthma controller therapy”, low levels of outdoor ozone were linked to respiratory abnormalities and other outcomes in African American children with difficult-to-treat asthma, even when they were using asthma medications, such as inhalers, to mitigate the harmful effects of air pollutants.
The Environmental Protection Agency (EPA) cooperated with researchers at the University of North Carolina at Chapel Hill to investigate the effects of ozone on the health of African American children with moderate-to-severe persistent asthma in Raleigh, North Carolina. The findings show that ozone levels below the National Ambient Air Quality Standard (NAAQS) were linked to pulmonary and other alterations in African American children with persistent asthma.
The American Lung Association Epidemiology and Statistics Unit through the CDC’s data showcased that Puerto Ricans in the US had the highest asthma rates at 14%, followed by African Americans at 11% and Non-Latino whites at 8%. This substantiates the fact that various ethnic groups are at a higher risk of asthma, which is driving the demand for asthma drugs in North America.
Furthermore, researchers discovered that even at low ozone levels and when the individuals took asthma medication, an increase in ozone concentrations was linked to a deterioration in lung function. They also discovered that ozone exposure was linked to a rise in the number of fatty compounds in the blood, previously observed only in adults. The study showed that even at low concentrations, ozone can impact vulnerable populations, and the effect is more extensive than merely respiratory outcomes.
The higher risks and vulnerabilities found in ethnic groups, especially Puerto Ricans and African Americans, propel the demand for asthma drugs for locations with higher density of these ethnic groups.
North America Asthma Drugs Market Revenue and Forecast to 2028 (US$ Mn)
Get more information on this report :
North America Asthma Drugs Market Segmentation
The North America asthma drugs market, by medication, is segmented into quick relief medications and long-term control medications. Based on route of administration, the market is segmented into inhaled, prefilled syringe/vials, and others. Based on distribution channel, the North America asthma drugs market is segmented into online pharmacies, hospital pharmacies, and retail pharmacies. By country, the market is segmented into the US, Canada, and Mexico.
AstraZeneca; TEVA PHARMACEUTICAL INDUSTRIES LTD; Boehringer Ingelheim International GmbH; GlaxoSmithKline plc.; Merck & Co., Inc.; Koninklijke Philips N.V.; Sanofi; Pfizer Inc. (Arena Pharmaceutical GmbH); Novartis AG; and Abbott are among the leading companies operating in the North America asthma drugs market.
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 North America Asthma Drugs Market – By Medication
1.3.2 North America Asthma Drugs Market – By Route of Administration
1.3.3 North America Asthma Drugs Market – By Distribution Channel
1.3.4 North America Asthma Drugs Market – By Country
2. Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. North America Asthma Drugs Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 North America – PEST Analysis
4.3 Expert Opinion
5. Asthma Drugs Market – Key Market Dynamics
5.1 Market Drivers
5.1.1 Growing Environmental Implications & Genetic Implications of Air Pollution
5.1.2 More Vulnerability in Specific Ethnic Groups
5.1.3 Growing Exposure to Coarse Particulate Matters
5.1.4 Growing Prevalence of Physiological Disorders Harboring Asthma
5.2 Market Restraints
5.2.1 Unmet Medical Needs
5.3 Market Opportunities
5.3.1 Opportunities with Commercialization of Biologics
5.4 Future Trends
5.4.1 Increasing Research Activities and Product Innovations
5.5 Impact Analysis
6. Asthma Drugs Market– North America Analysis
6.1 North America Asthma Drugs Market Revenue Forecast and Analysis
7. Asthma Drugs Market Analysis – by Medication
7.1 Overview
7.2 Asthma Drugs Market Revenue Share, by Medication (2021 and 2028)
7.3 Quick Relief Medications
7.3.1 Overview
7.3.2 Quick Relief Medications: Asthma Drugs Market – Revenue and Forecast to 2028 (US$ Million)
7.4 Long-term Control Medications
7.4.1 Overview
7.4.2 Long-term Control Medications: Asthma Drugs Market – Revenue and Forecast to 2028 (US$ Million)
8. Asthma Drugs Market Analysis – By Route of Administration
8.1 Overview
8.2 Asthma Drugs Market Revenue Share, By Route of Administration (2021 and 2028)
8.3 Inhaled
8.3.1 Overview
8.3.2 Inhaled: Asthma Drugs Market– Revenue and Forecast to 2028 (USD Million)
8.4 Prefilled Syringe/Vials
8.4.1 Overview
8.4.2 Prefilled Syringe/Vials: Asthma Drugs Market– Revenue and Forecast to 2028 (USD Million)
8.5 Others (Oral, Nasal, Ophthalmic Etc.)
8.5.1 Overview
8.5.2 Others: Asthma Drugs Market– Revenue and Forecast to 2028 (USD Million)
9. Asthma Drugs Market Analysis – By Distribution Channel
9.1 Overview
9.2 Asthma Drugs Market Revenue Share, By Distribution Channel (2021 and 2028)
9.3 Online Pharmacies
9.3.1 Overview
9.3.2 Online Pharmacies: Asthma Drugs Market– Revenue and Forecast to 2028 (USD Million)
9.4 Hospital Pharmacies
9.4.1 Overview
9.4.2 Hospital Pharmacies: Asthma Drugs Market– Revenue and Forecast to 2028 (USD Million)
9.5 Retail Pharmacies and Drugstores
9.5.1 Overview
9.5.2 Retail Pharmacies and Drugstores: Asthma Drugs Market– Revenue and Forecast to 2028 (USD Million)
10. Asthma Drugs Market – North America Analysis
10.1 North America: Asthma Drugs Market Revenue and Forecast to 2028
10.1.1 Overview
10.1.2 North America: Asthma Drugs Market – Revenue and Forecast to 2028 (USD Million)
10.1.3 North America: Asthma Drugs Market, by Medication, 2019–2028 (USD Million)
10.1.4 North America: Asthma Drugs Market, by Route of Administration, 2019–2028 (USD Million)
10.1.5 North America: Asthma Drugs Market, by Distribution Channel, 2019–2028 (USD Million)
10.1.6 North America: Asthma Drugs Market, by Country, 2021 & 2028 (%)
10.1.6.1 US: Asthma Drugs Market – Revenue and Forecast to 2028 (USD Million)
10.1.6.1.1 US: Asthma Drugs Market – Revenue and Forecast to 2028 (USD Million)
10.1.6.1.2 US: Asthma Drugs Market, by Medication, 2019–2028 (USD Million)
10.1.6.1.3 US: Asthma Drugs Market, by Route of Administration, 2019–2028 (USD Million)
10.1.6.1.4 US: Asthma Drugs Market, by Distribution Channel, 2019–2028 (USD Million)
10.1.6.2 Canada: Asthma Drugs Market – Revenue and Forecast to 2028 (USD Million)
10.1.6.2.1 Canada: Asthma Drugs Market – Revenue and Forecast to 2028 (USD Million)
10.1.6.2.2 Canada: Asthma Drugs Market, by Medication, 2019–2028 (USD Million)
10.1.6.2.3 Canada: Asthma Drugs Market, by Route of Administration, 2019–2028 (USD Million)
10.1.6.2.4 Canada: Asthma Drugs Market, by Distribution Channel, 2019–2028 (USD Million)
10.1.6.3 Mexico: Asthma Drugs Market – Revenue and Forecast to 2028 (USD Million)
10.1.6.3.1 Mexico: Asthma Drugs Market – Revenue and Forecast to 2028 (USD Million)
10.1.6.3.2 Mexico: Asthma Drugs Market, by Medication, 2019–2028 (USD Million)
10.1.6.3.3 Mexico: Asthma Drugs Market, by Route of Administration, 2019–2028 (USD Million)
10.1.6.3.4 Mexico: Asthma Drugs Market, by Distribution Channel, 2019–2028 (USD Million)
11. Asthma Drugs Market–Industry Landscape
11.1 Overview
11.2 Organic Developments
11.2.1 Overview
11.3 Inorganic Developments
11.3.1 Overview
12. Company Profiles
12.1 AstraZeneca
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 TEVA PHARMACEUTICAL INDUSTRIES LTD
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 GlaxoSmithKline plc.
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 Boehringer Ingelheim International GmbH
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Merck & Co., Inc.
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 Koninklijke Philips N.V.
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 Sanofi
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 Pfizer Inc. (Arena Pharmaceutical GmbH)
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments
12.9 Novartis AG
12.9.1 Key Facts
12.9.2 Business Description
12.9.3 Products and Services
12.9.4 Financial Overview
12.9.5 SWOT Analysis
12.9.6 Key Developments
12.10 Abbott
12.10.1 Key Facts
12.10.2 Business Description
12.10.3 Products and Services
12.10.4 Financial Overview
12.10.5 SWOT Analysis
12.10.6 Key Developments
13. Appendix
13.1 About The Insight Partners
13.2 Glossary of Terms
LIST OF TABLES
Table 1. Odds Ratio (OR) For Mental Disorders among Adults with Asthma Vs Without Asthma
Table 2. Asthma Death Rates for Select Countries, 2018
Table 3. Common SABAs
Table 4. Commonly inhaled corticosteroids
Table 5. North America: Asthma Drugs Market, by Medication – Revenue and Forecast to 2028 (USD Million)
Table 6. North America: Asthma Drugs Market, by Route of Administration – Revenue and Forecast to 2028 (USD Million)
Table 7. North America: Asthma Drugs Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)
Table 8. US: Asthma Drugs Market, by Medication – Revenue and Forecast to 2028 (USD Million)
Table 9. US: Asthma Drugs Market, by Route of Administration – Revenue and Forecast to 2028 (USD Million)
Table 10. US: Asthma Drugs Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)
Table 11. Canada: Asthma Drugs Market, by Medication – Revenue and Forecast to 2028 (USD Million)
Table 12. Canada: Asthma Drugs Market, by Route of Administration – Revenue and Forecast to 2028 (USD Million)
Table 13. Canada: Asthma Drugs Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)
Table 14. Mexico: Asthma Drugs Market, by Medication – Revenue and Forecast to 2028 (USD Million)
Table 15. Mexico: Asthma Drugs Market, by Route of Administration – Revenue and Forecast to 2028 (USD Million)
Table 16. Mexico: Asthma Drugs Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)
Table 17. Organic Developments in the Asthma Drugs Market
Table 18. Inorganic Developments in the Asthma Drugs Market
Table 19. Glossary of Terms, Asthma Drugs Market
LIST OF FIGURES
Figure 1. Asthma Drugs Market Segmentation
Figure 2. Asthma Drugs Market, By Country
Figure 3. Europe Asthma Drugs Market Overview
Figure 4. The Long Term Control Medications Segment Held Largest Share of Mode of Service in the Asthma Drugs Market
Figure 6. North America Asthma Drugs Market- Leading Country Markets (US$ Million)
Figure 7. North America PEST Analysis
Figure 8. Expert Opinion
Figure 9. Impact of Low Mood/Anxiety on Asthma
Figure 10. Asthma Drugs Market Impact Analysis of Drivers and Restraints
Figure 11. North America Asthma Drugs Market– Revenue Forecast and Analysis – 2020- 2028
Figure 12. Asthma Drugs Market Revenue Share, by Medication (2021 and 2028)
Figure 13. Quick Relief Medications: Asthma Drugs Market – Revenue and Forecast to 2028 (US$ Million)
Figure 14. Long-term Control Medications: Asthma Drugs Market – Revenue and Forecast to 2028 (US$ Million)
Figure 15. Asthma Drugs Market Share, By Route of Administration, 2021 and 2028 (%)
Figure 16. Inhaled: Asthma Drugs Market– Revenue and Forecast to 2028 (USD Million)
Figure 17. Prefilled Syringe/Vials: Asthma Drugs Market– Revenue and Forecast to 2028 (USD Million)
Figure 18. Others: Asthma Drugs Market– Revenue and Forecast to 2028 (USD Million)
Figure 19. Asthma Drugs Market Share, By Distribution Channel, 2021 and 2028 (%)
Figure 20. Online Pharmacies: Asthma Drugs Market– Revenue and Forecast to 2028 (USD Million)
Figure 21. Hospital Pharmacies: Asthma Drugs Market– Revenue and Forecast to 2028 (USD Million)
Figure 22. Retail Pharmacies and Drugstores: Asthma Drugs Market– Revenue and Forecast to 2028 (USD Million)
Figure 23. North America: Asthma Drugs Market, by Key Country – Revenue (2021) (USD Million)
Figure 24. North America: Asthma Drugs Market Revenue and Forecast to 2028 (USD Million)
Figure 25. North America: Asthma Drugs Market, by Country, 2021 & 2028 (%)
Figure 26. Prevalence of Asthma by Age, Sex, and Race/Ethnicity, 2019
Figure 27. US: Asthma Drugs Market – Revenue and Forecast to 2028 (USD Million)
Figure 28. Prevalence of Diagnosed Asthma Among Canadians (%), By Age Group and Sex, 2011-12
Figure 29. Age-Standardized Prevalence of Diagnosed Asthma Among Canadians, by Sex and Year
Figure 30. Canada: Asthma Drugs Market – Revenue and Forecast to 2028 (USD Million)
Figure 31. Mexico: Asthma Drugs Market – Revenue and Forecast to 2028 (USD Million)
- AstraZeneca
- TEVA PHARMACEUTICAL INDUSTRIES LTD
- GlaxoSmithKline plc.
- Boehringer Ingelheim International GmbH
- GlaxoSmithKline plc.
- Merck & Co., Inc.
- Koninklijke Philips N.V.
- Sanofi
- Pfizer Inc. (Arena Pharmaceutical GmbH)
- Novartis AG
- Abbott
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the North America asthma drugs market.
- Highlights key business priorities in order to assist companies to realign their business strategies.
- The key findings and recommendations highlight crucial progressive industry trends in the North America asthma drugs market, thereby allowing players across the value chain to develop effective long-term strategies.
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
- Scrutinize in-depth market trends and outlook coupled with the factors driving the market, as well as those hindering it.
- Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.